Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evercore ISI Group Maintains In-Line on Doximity, Maintains $30 Price Target

Author: Benzinga Newsdesk | April 02, 2024 07:03am
Evercore ISI Group analyst Elizabeth Anderson maintains Doximity (NYSE:DOCS) with a In-Line and maintains $30 price target.

Posted In: DOCS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist